Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion description "[The high potency, significant gene induction, excellent PK profiles, and good in vivo efficacies in three animal models may render compound 24 as a valuable pharmacological tool in elucidating the complex roles of PPARalpha/delta dual agonists and as a potential treatment of the metabolic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion evidence source_evidence_literature NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion SIO_000772 17608467 NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion wasDerivedFrom befree-2016 NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_assertion wasGeneratedBy ECO_0000203 NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.
- befree-2016 importedOn "2016-02-19" NP618274.RAU5cOfBwDhB9x5j0pANqqhmK0pSXVBD5_ywT4H3ED53c130_provenance.